EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Long‐Term Follow‐Up Incidence of Type 1 Diabetes and Associated Autoimmune Diseases in First‐Degree Relatives

Julie H Christensen, Gitte Lindved Petersen, Simranjeet Kaur, Alexander Lind, Samia Hamdan, Maria Naredi Scherman, Jesper Johannesen, Daniel Agardh, Julie C Antvorskov, Flemming Pociot iD

Diabetes, Obesity and Metabolism · 2026

DOI: 10.1111/dom.71194 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Diabetes, Obesity and Metabolism, 2026. Verfasst von Julie H Christensen und 9 weiteren Autor:innen. Beteiligte Einrichtung: Translational Type 1 Diabetes Research, Clinical Research, Steno Diabetes Center Copenhagen, Herlev, Denmark. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 1, Autoimmune Diseases, Thyroiditis, Autoimmune, Celiac Disease. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Region Skåne, Capital Region of Denmark, Novo Nordisk Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

First‐degree relatives (FDRs) of individuals with type 1 diabetes (T1D) carry a significantly elevated risk of developing autoimmune diseases, including celiac disease (CD) and autoimmune thyroid disease (AITD). The DiaUnion 1.0 study aimed to characterize one‐time autoantibodies, genetic risk profiles and long‐term progression to T1D, CD or AITD in siblings of children newly diagnosed with T1D.

Methods

Between 1997 and 2010, 1427 Danish siblings provided plasma and DNA samples to the DanDiabKids biobank. Autoantibodies associated with T1D (GADA, IAA, IA2A, ZnT8A), CD (tTGA) and AITD (TPOA) were measured using ADAP technology and confirmed by radiobinding assays. Genotyping was performed to compute a T1D Genetic Risk Score (GRS). National registry data were used to track disease incidence up to year 2024.

Results

Out of 1417 screened samples, 7.8% were positive for islet autoantibodies (IAab), and 4.6% had multiple IAab. Disease incidence rate increased substantially with IAab positivity: 0.11 per 100 person‐years in IAab‐negative siblings, 2.46 in single‐IAab positive and 8.10 in those with multiple IAab. Similarly, 1.97 per 100 person‐years of tTGA‐positive siblings developed CD, and 0.69 per 100 person‐years of TPOA‐positive individuals developed AITD. Higher GRS and HLA DR3/DR4 haplotypes were associated with autoantibody positivity ( p < 0.0001).

Conclusions

A single screening for T1D, CD and AITD autoantibodies combined with genetic risk scoring stratified long‐term risk of clinically diagnosed autoimmune disease. These findings support further evaluation of targeted screening and follow‐up strategies in FDRs to enable surveillance and potential early intervention before clinical onset.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes Mellitus, Type 1Autoimmune DiseasesThyroiditis, AutoimmuneCeliac DiseaseHumansFemaleMaleIncidenceFollow-Up StudiesAutoantibodiesChildAdolescentDenmarkGenetic Predisposition to DiseaseChild, PreschoolSiblingsAdultGenetic Risk ScoreFamilyDisease Progression

Stichwörter der Autor:innen

autoimmunitycohort studydatabase researchfirst‐degree relativestype 1 diabetes

Substanzen

Autoantibodies

Autor:innen und Institutionen

  • Translational Type 1 Diabetes Research, Clinical Research, Steno Diabetes Center Copenhagen, Herlev, Denmark.
  • Department of Clinical Sciences, Lund University CRC, Skåne University Hospital, Malmö, Sweden.
  • Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.

ORCID-Profile: Flemming Pociot

Förderung

  • Region Skåne
  • Capital Region of Denmark
  • Novo Nordisk Foundation
  • EU Interreg ÖKS
  • Barndiabetesfonden
  • Lund University
  • Steno Diabetes Center Copenhagen (SDCC)
  • Region Hovedstaden

Zitieren

APA

Christensen, J. H., Petersen, G. L., Kaur, S., Lind, A., Hamdan, S., Scherman, M. N., Johannesen, J., Agardh, D., Antvorskov, J. C., & Pociot, F. (2026). Long‐Term Follow‐Up Incidence of Type 1 Diabetes and Associated Autoimmune Diseases in First‐Degree Relatives. Diabetes, Obesity and Metabolism. https://doi.org/10.1111/dom.71194

Vancouver

Christensen JH, Petersen GL, Kaur S, Lind A, Hamdan S, Scherman MN, et al. Long‐Term Follow‐Up Incidence of Type 1 Diabetes and Associated Autoimmune Diseases in First‐Degree Relatives. Diabetes, Obesity and Metabolism. 2026. doi:10.1111/dom.71194

BibTeX
@article{Christensen2026,
  author = {Christensen, Julie H and Petersen, Gitte Lindved and Kaur, Simranjeet and Lind, Alexander and Hamdan, Samia and Scherman, Maria Naredi and Johannesen, Jesper and Agardh, Daniel and Antvorskov, Julie C and Pociot, Flemming},
  title = {Long‐Term Follow‐Up Incidence of Type 1 Diabetes and Associated Autoimmune Diseases in First‐Degree Relatives},
  journal = {Diabetes, Obesity and Metabolism},
  year = {2026},
  doi = {10.1111/dom.71194}
}
Kostenlos starten →